Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicaid AMPs Ratcheted Down To 150% In President’s 2008 Budget

Executive Summary

Even though CMS is still working on rules to revise Medicaid's prescription drug reimbursement formula, the agency is proposing to reduce its payments to state Medicaid programs that are based on that formula

You may also be interested in...



Budget Pushes For ESA Bundling, Repeats Medicaid AMP Proposal

Amidst continued scrutiny of erythropoiesis-stimulating agents, the White House's fiscal 2009 budget proposes the bundling of dialysis products and services. This would save the government $10 million in FY '09 and nearly $1.1 billion from fiscal 2009-2013, according to CMS budget documents

Budget Pushes For ESA Bundling, Repeats Medicaid AMP Proposal

Amidst continued scrutiny of erythropoiesis-stimulating agents, the White House's fiscal 2009 budget proposes the bundling of dialysis products and services. This would save the government $10 million in FY '09 and nearly $1.1 billion from fiscal 2009-2013, according to CMS budget documents

Legislators AMPlify Pharmacy Medicaid Concerns

Pharmacy groups worried about the impact of Medicaid's proposed changes in prescription drug payment have found friends in Congress who contend that the changes go beyond congressional intent

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS048021

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel